HGEN
Closed
Humanigen Inc
0.0001
0.0000 (0.00%)
Last Update: 07 Mar 2024 17:30:00
Yesterday: 0.0001
Day's Range: 0.0001 - 0.0001
Send
sign up or login to leave a comment!
When Written:
0.139
Humanigen Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing proprietary monoclonal antibodies for the treatment of infectious diseases and cancer. The company's lead product candidate is lenzilumab, a monoclonal antibody that is being developed for the treatment of cytokine storm associated with COVID-19 and other indications. Humanigen is also developing a pipeline of monoclonal antibodies for the treatment of various cancers. The company was founded in 2000 and is headquartered in Burlingame, California.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








